Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma

키워드

참고문헌 (7)

1. Manns MP, "Hepatitis C virus infection", Nat Rev Dis Primers, 3, pp.17006~ (2017)
2. European Association for the Study of the Liver, "EASL recommendations on treatment of hepatitis C: final update of the series", J Hepatol, 73, pp.1170~1218 (2020)
3. Ghany MG, "Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection", Hepatology, 71, pp.686~721 (2020)
4. Cabibbo G, "Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?", Liver Int, 38, pp.2108~2116 (2018)
5. Ji F, "Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma : a systematic review and meta-analysis", J Hepatol, 71, pp.473~485 (2019)
6. He S, "Systematic review with meta-analysis : effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma", Aliment Pharmacol Ther, 51, pp.34~52 (2020)
7. Byung Soo Kwan, "Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma", The Korean Journal of Internal Medicine, 36(2), pp.292~304 (2021), 대한내과학회[DOI]

관련 논문AI추천